AVTX

Avalo Therapeutics News - AVTX

Buy
Sell
Best deals to access real time data!
USA CHART Trader
Monthly Subscription
for only
US$30.66
Real-time Level 1 for Canada + USA
Monthly Subscription
for only
US$38.05
USA Small Cap Basic
Monthly Subscription
for only
US$33.03
VAT not included
Stock Name Stock Symbol Market Stock Type
Avalo Therapeutics Inc AVTX NASDAQ Common Stock
  Price Change Price Change % Stock Price Last Trade
-0.0207 -6.45% 0.3001 06:02:00
Open Price Low Price High Price Close Price Previous Close
0.32 0.2957 0.3368 0.3001 0.3208
more quote information »

Recent News

Date Time Source Heading
24/5/202221:04EDGARCurrent Report Filing (8-k)
18/5/202221:30GLOBEAvalo Therapeutics Announces First Patient Dosed in the..
18/5/202205:46EDGARStatement of Ownership (sc 13g)
17/5/202221:30GLOBEAvalo to Present at the H.C. Wainwright Global Life Sciences..
05/5/202221:30GLOBEAvalo Therapeutics First Quarter 2022 Financial Results..
26/4/202206:05EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
26/4/202206:02EDGARProxy Statement (definitive) (def 14a)
05/4/202208:07EDGARStatement of Changes in Beneficial Ownership (4)
05/4/202207:38EDGARStatement of Changes in Beneficial Ownership (4)
19/3/202207:06EDGARCurrent Report Filing (8-k)
16/3/202222:32EDGARCurrent Report Filing (8-k)
15/3/202208:39EDGARStatement of Changes in Beneficial Ownership (4)
11/3/202209:38EDGARStatement of Changes in Beneficial Ownership (4)
08/3/202223:00GLOBEAvalo to Present at Oppenheimer's 32nd Annual Healthcare..
08/3/202210:10EDGARStatement of Changes in Beneficial Ownership (4)
03/3/202208:10EDGARAnnual Report (10-k)
02/3/202223:49SEEKAvalo Therapeutics GAAP EPS of -$0.83 in-line, revenue of..
02/3/202223:30GLOBEAvalo Therapeutics Reports 2021 Financial Results..
19/2/202208:02EDGARCurrent Report Filing (8-k)
18/2/202200:12SEEKAvalo Therapeutics picks internal candidate for CEO and CFO..
17/2/202223:30GLOBEAvalo Therapeutics Announces Leadership Transition
15/2/202209:02EDGARAmended Statement of Ownership (sc 13g/a)
15/2/202200:07EDGARAmended Statement of Ownership (sc 13g/a)
08/2/202208:01GLOBEAvalo Therapeutics to Present at the 2022 BIO CEO and..
21/1/202210:15EDGARStatement of Changes in Beneficial Ownership (4)
15/1/202209:50EDGARStatement of Changes in Beneficial Ownership (4)
12/1/202210:19EDGARStatement of Changes in Beneficial Ownership (4)
11/1/202219:32SEEKNew commercial chief at Avalo Therapeutics
11/1/202211:58GLOBEAvalo Therapeutics Appoints Stephen Smolinski as Chief..
10/1/202212:55TRMNAvalo Therapeutics (AVTX) Gets a Buy Rating from RBC Capital
07/1/202208:20EDGARStatement of Changes in Beneficial Ownership (4)
07/1/202208:17EDGARInitial Statement of Beneficial Ownership (3)
07/1/202202:24SEEKAvalo Therapeutics discontinues multiple myeloma program;..
06/1/202223:56EDGARCurrent Report Filing (8-k)
06/1/202223:30GLOBEAvalo Reports Positive Phase 1b Results for AVTX-002 in..
05/1/202208:28EDGARStatement of Changes in Beneficial Ownership (4)
05/1/202208:28EDGARStatement of Changes in Beneficial Ownership (4)
05/1/202208:28EDGARStatement of Changes in Beneficial Ownership (4)
16/12/202123:30GLOBEAvalo Therapeutics to Host Virtual Investor Day on January..
16/12/202108:02EDGARCurrent Report Filing (8-k)
15/12/202110:20EDGARStatement of Changes in Beneficial Ownership (4)
15/12/202109:16EDGARStatement of Changes in Beneficial Ownership (4)
15/12/202109:14EDGARStatement of Changes in Beneficial Ownership (4)
06/12/202123:30GLOBEAvalo Appoints Two New Independent Directors to Its Board
13/11/202108:23EDGARStatement of Changes in Beneficial Ownership (4)
13/11/202108:13EDGARInitial Statement of Beneficial Ownership (3)
13/11/202108:04EDGARStatement of Changes in Beneficial Ownership (4)
11/11/202123:00GLOBEAvalo to Present at Two Upcoming Conferences
10/11/202108:54SEEKAvalo Therapeutics EPS beats by $0.01, beats on revenue
10/11/202108:17EDGARQuarterly Report (10-q)
Your Recent History
NASDAQ
AVTX
Avalo Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220526 02:27:32